Accurant BioTechnology Co.
Latest round
- Series B
Last raised
- Jan 2022
Total raised
- $36M
Investors
- 7
About Accurant BioTechnology Co.
Established in 2017 and based in Ningbo, China, Accurant Biotech is a laboratory that provides clinical and preclinical macromolecular bioanalysis services. Dr. Xiaoyan Cai, the founder and CEO of the company, served as the global head of WuXi AppTec's macromolecular bioanalysis department and the director of Schering-Plough Biopharmaceutical Analysis Research and Development. The company has labs in Ningbo, Shanghai, New Jersey. The services of the company can be categorized into four categories which are large molecule bioanalysis, conpanion diagnostic, product release detection and cell line construction. The technology platforms include cell platform, immunization platform, gene platform, cell chamber and BSL-2 laboratory. Bioanalytical services include antibody preparation and cell line construction, covering pharmacokinetics (PK), pharmacodynamics (PD), anti-drug antibody (ADA), neutralizing antibody (NAb), and biomarker assays. Concomitant diagnostic product development services include LDT methodology development, development and validation, registration testing, clinical trial studies and registration filings of CDx product. The company has cooperation with China Resources Pharmaceutical Group Limited and other enterprises. The company plans to expand technical service capacity, accelerate the development of concomitant diagnostic product development business, and further strengthen the service capability of providing one-stop technical solutions for testing and analysis for clinical and preclinical studies of biological drugs.
Who invested in Accurant BioTechnology Co.
7 investors across 4 rounds
See all investors in Accurant BioTechnology Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Accurant BioTechnology Co.
Who invested in Accurant BioTechnology Co.?
Accurant BioTechnology Co. has 7 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Accurant BioTechnology Co. raised?
Accurant BioTechnology Co. has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Accurant BioTechnology Co. last raise money?
Accurant BioTechnology Co.'s most recent round on record is a Series B, in Jan 2022.
What does Accurant BioTechnology Co. do?
Established in 2017 and based in Ningbo, China, Accurant Biotech is a laboratory that provides clinical and preclinical macromolecular bioanalysis services.
Where is Accurant BioTechnology Co. headquartered?
Accurant BioTechnology Co. is headquartered in Ningbo, China.
Which VCs invest in companies like Accurant BioTechnology Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Accurant BioTechnology Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Accurant BioTechnology Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.